Marina Bozilenko resigns from Board of Directors of SynAct Pharma

SynAct Pharma AB (publ) ("SynAct") announced today Marina Bozilenko has notified the Board of her resignation as member of the Board of Directors due to personal reasons.

“We are grateful for Marina’s time and effort serving on the Board. She has been a valuable asset to SynAct. We wish her the best of luck,” said SynAct Chairman Uli Hacksell.

“I very much enjoyed working with the management team and Board of Directors of SynAct, but unfortunately my personal and professional commitments have increased a great deal and I am no longer able to contribute adequate time and effort to SynAct.  I resign my position with regret and wish the company and everyone involved a productive and successful future,” said Marina Bozilenko.

For further information, please contact:

Uli Hacksell
Chairman, SynAct Pharma AB
Email: [email protected]